Clinical Trial

Zoster Eye Disease Study

Study Description

Zoster Eye Disease Study

This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.


Locations Selected Location


Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Masked Placebo

Oral Placebo

Drug - Masked Oral Valacyclovir

Oral Valacyclovir 1000 mg/day

Additional Information

Official Study Title

Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus

Clinical Trial ID


ParticipAid ID